German Federal Ministry of Education and Research
The German Federal Ministry of Education and Research (BMBF) is the pioneering Western government funder of large-scale psychedelic clinical trials, having provided approximately €5 million to the EPIsoDE study — the first government-funded Phase 2 psilocybin trial for treatment-resistant major depression — conducted at the Central Institute for Mental Health in Mannheim and Charité Berlin. Germany subsequently became the first EU country to establish a psilocybin compassionate access program for treatment-resistant depression.
Foundations & Philanthropy Snapshot
Grant-Making OrganizationsClassification
Grant Program (Host Organization)
Geography
Global
Coverage
Global
Last Verified
Apr 10, 2026
Funding Focus Areas
Support Types
Philanthropy Notes
Auto-backfilled baseline philanthropy profile from existing category tags and website. Manual enrichment recommended for recipient-level details.
Verification
Verified
Psychedelic Focus
Psychedelic-Adjacent Focus
Engagement Status
Active
Verification Notes
Verified against official BMBF research funding pages.
Quick Facts
- Type
- Other
- HQ
- Germany
- Website
- Visit